146 related articles for article (PubMed ID: 28211980)
1. Constitutional bone impairment in Noonan syndrome.
Baldassarre G; Mussa A; Carli D; Molinatto C; Ferrero GB
Am J Med Genet A; 2017 Mar; 173(3):692-698. PubMed ID: 28211980
[TBL] [Abstract][Full Text] [Related]
2. A novel heterozygous RIT1 mutation in a patient with Noonan syndrome, leukopenia, and transient myeloproliferation-a review of the literature.
Nemcikova M; Vejvalkova S; Fencl F; Sukova M; Krepelova A
Eur J Pediatr; 2016 Apr; 175(4):587-92. PubMed ID: 26518681
[TBL] [Abstract][Full Text] [Related]
3. A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.
Gripp KW; Aldinger KA; Bennett JT; Baker L; Tusi J; Powell-Hamilton N; Stabley D; Sol-Church K; Timms AE; Dobyns WB
Am J Med Genet A; 2016 Sep; 170(9):2237-47. PubMed ID: 27264673
[TBL] [Abstract][Full Text] [Related]
4. Decreased bone mineralization in children with Noonan syndrome: another consequence of dysregulated RAS MAPKinase pathway?
Choudhry KS; Grover M; Tran AA; O'Brian Smith E; Ellis KJ; Lee BH
Mol Genet Metab; 2012 Jun; 106(2):237-40. PubMed ID: 22551697
[TBL] [Abstract][Full Text] [Related]
5. Objective studies of the face of Noonan, Cardio-facio-cutaneous, and Costello syndromes: A comparison of three disorders of the Ras/MAPK signaling pathway.
Allanson JE
Am J Med Genet A; 2016 Oct; 170(10):2570-7. PubMed ID: 27155212
[TBL] [Abstract][Full Text] [Related]
6. [Noonan syndrome: from phenotype to growth hormone therapy].
Malaquias AC; Ferreira LV; Souza SC; Arnhold IJ; Mendonça BB; Jorge AA
Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):800-8. PubMed ID: 18797587
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of pubertal development and gonadal function in Noonan syndrome.
Patti G; Scaglione M; Maiorano NG; Rosti G; Divizia MT; Camia T; De Rose EL; Zucconi A; Casalini E; Napoli F; Di Iorgi N; Maghnie M
Front Endocrinol (Lausanne); 2023; 14():1213098. PubMed ID: 37576960
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
[TBL] [Abstract][Full Text] [Related]
9. [Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway].
Ejarque I; Millán-Salvador JM; Oltra S; Pesudo-Martínez JV; Beneyto M; Pérez-Aytés A
Rev Neurol; 2015 May; 60(9):408-12. PubMed ID: 25912702
[TBL] [Abstract][Full Text] [Related]
10. Variants of SOS2 are a rare cause of Noonan syndrome with particular predisposition for lymphatic complications.
Lissewski C; Chune V; Pantaleoni F; De Luca A; Capri Y; Brinkmann J; Lepri F; Daniele P; Leenders E; Mazzanti L; Scarano E; Radio FC; Kutsche K; Kuechler A; Gérard M; Ranguin K; Legendre M; Vial Y; van der Burgt I; Rinne T; Andreucci E; Mastromoro G; Digilio MC; Cave H; Tartaglia M; Zenker M
Eur J Hum Genet; 2021 Jan; 29(1):51-60. PubMed ID: 32788663
[TBL] [Abstract][Full Text] [Related]
11. [RAS/MAPK signal transduction pathway and its role in the pathogenesis of Noonan syndrome].
Gos M; Leszkiewicz M; Abramowicz A
Postepy Biochem; 2012; 58(3):255-64. PubMed ID: 23373411
[TBL] [Abstract][Full Text] [Related]
12. Prenatal features of Noonan syndrome: prevalence and prognostic value.
Baldassarre G; Mussa A; Dotta A; Banaudi E; Forzano S; Marinosci A; Rossi C; Tartaglia M; Silengo M; Ferrero GB
Prenat Diagn; 2011 Oct; 31(10):949-54. PubMed ID: 21744363
[TBL] [Abstract][Full Text] [Related]
13. IGF-I generation test in prepubertal children with Noonan syndrome due to mutations in the PTPN11 gene.
Bertelloni S; Baroncelli GI; Dati E; Ghione S; Baldinotti F; Toschi B; Simi P
Hormones (Athens); 2013; 12(1):86-92. PubMed ID: 23624134
[TBL] [Abstract][Full Text] [Related]
14. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
[TBL] [Abstract][Full Text] [Related]
15. Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype.
Ekvall S; Hagenäs L; Allanson J; Annerén G; Bondeson ML
Am J Med Genet A; 2011 Jun; 155A(6):1217-24. PubMed ID: 21548061
[TBL] [Abstract][Full Text] [Related]
16. [A case report of Noonan syndrome diagnosed in primary healthcare].
Villaroel-Vargas J; Molina-Vargas L; Zurita-Leal A; Zavala-Calahorrano A
Medwave; 2020 Feb; 20(2):e7826. PubMed ID: 32119651
[TBL] [Abstract][Full Text] [Related]
17. Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients.
Li X; Yao R; Tan X; Li N; Ding Y; Li J; Chang G; Chen Y; Ma L; Wang J; Fu L; Wang X
Clin Genet; 2019 Oct; 96(4):290-299. PubMed ID: 31219622
[TBL] [Abstract][Full Text] [Related]
18. GH Therapy and first final height data in Noonan-like syndrome with loose anagen hair (Mazzanti syndrome).
Mazzanti L; Tamburrino F; Scarano E; Perri A; Vestrucci B; Guidetti M; Rossi C; Tartaglia M
Am J Med Genet A; 2013 Nov; 161A(11):2756-61. PubMed ID: 24124081
[TBL] [Abstract][Full Text] [Related]
19. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
Nava C; Hanna N; Michot C; Pereira S; Pouvreau N; Niihori T; Aoki Y; Matsubara Y; Arveiler B; Lacombe D; Pasmant E; Parfait B; Baumann C; Héron D; Sigaudy S; Toutain A; Rio M; Goldenberg A; Leheup B; Verloes A; Cavé H
J Med Genet; 2007 Dec; 44(12):763-71. PubMed ID: 17704260
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic variability associated with the invariant SHOC2 c.4A>G (p.Ser2Gly) missense mutation.
Baldassarre G; Mussa A; Banaudi E; Rossi C; Tartaglia M; Silengo M; Ferrero GB
Am J Med Genet A; 2014 Dec; 164A(12):3120-5. PubMed ID: 25331583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
